Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir, and depending on the genotype and underlying medical conditions, with or without ribavirin.
